BioNTech
Blood & Organ Banks · Germany · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
An Der Goldgrube 12, Mainz, Rheinland-Pf...Phone Number
+49 613190840Website
www.biontech.comRevenue
$3.3 BillionStock Symbol
BNTXIndustry
ZI Rank: 27
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
31
29
18
16
33
27
About BioNTech
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseasesExplore more
BioNTech Org Chart
CO
Executive Director, Medical Affairs Operation...
NB
Head Executive Director, National Field Medic...
AP
Executive Director, Systems Immunology
GD
Executive Director, Patient Services & Soluti...
ML
Global Senior Director, Regulatory Affairs De...
AS
Global Medical Affairs Oncology Senior Direct...
AZ
Senior Director, Clinical Operations
FE
Head Senior Director, Quantitative Clinical P...
SW
Senior Director, Clinical Pharmacology and Ph...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioNTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if BioNTech has recently received funding, and reach out quickly before it becomes old news!
Click to see if BioNTech had a recent Job posting/layoffs
Earning: See what the market has to say on BioNTech recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioNTech
Product Launch: Get notified when BioNTech launches new products
Check out if BioNTech is spiking on competitors!
BioNTech, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once BioNTech has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
BioNTech is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
BioNTech is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about BioNTech.
BioNTech financials insights
Gather financial insights about BioNTech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$270M
2019
Series B
$325M
Other Financing Round
$55.7M
2020
Multiple Rounds
$694.8M
BioNTech Tech Stack
A closer look at the technologies used by BioNTech
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
BioNTech News & Media
Is BioNTech SE (BNTX) A Good Stock To Buy Now?
Is BNTX a good stock to buy? We came across a bullish thesis on BioNTech SE on r/ValueInvesting by birdflustocks. In this article, we will summarize the bulls’ thesis on BNTX. BioNTech SE’s share was trading at $86.50 as of June 9th. BNTX’s trailing and forward P/E were 166.87 and 7.04 respectively according to Yahoo Finance. BioNTech […]BioNTech (BNTX) and Bristol Myers Share New Results From ROSETTA Lung-02 Study
BioNTech SE (NASDAQ:BNTX) is one of the best healthcare stocks to buy with highest upside potential. BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Company announced on May 30 interim Phase 2 data from the global Phase 2/3 ROSETTA Lung-02 clinical trial evaluating the investigational PD-L1xVEGF-A bispecific immunomodulator pumitamig plus chemotherapy in patients with previously untreated advanced […]The Multi-Billion-Dollar Search for Better Glioblastoma Treatments
Yet one of oncology's greatest challenges, Glioblastoma, remains largely unsolved.Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
BioNTech and BMS' PD-L1xVEGF-A bispecific pumitamig shows encouraging efficacy in patients with non-small cell lung cancer in ROSETTA Lung-02 trial
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioNTech
Sign Up For FreeTo access detailed company insights
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases... Read More
